Pharmacists in Santa Fe Springs, California


28 Pharmacists found in Santa Fe Springs
female pharmacist

Melissa Chan-wei Kuo, PHARM. D.


Pharmacist
10621 Carmenita Rd, T-0227, Santa Fe Springs, CA 90670
714-883-2123    

male pharmacist

Mina Samy Moussa


Pharmacist
12540 Mccann Dr, Santa Fe Springs, CA 90670
424-205-0150    

male pharmacist

Dr. Mohamed Sherman Mouissat, PHARMD


Pharmacist
11980 Telegraph Rd Ste 102, Santa Fe Springs, CA 90670
562-270-5374     562-860-7183



female pharmacist

Quynh Thuy Nguyen, RPH


Pharmacist
12874 Florence Ave, Santa Fe Springs, CA 90670
800-834-8778    

female pharmacist

Quynhanh Le


Pharmacist
13310 Telegraph Rd, Santa Fe Springs, CA 90670
562-946-6935     562-946-9045

female pharmacist

Dr. Teri Lee Molthen, PHARM. D.


Pharmacist
11980 Telegraph Rd, Suite 102, Santa Fe Springs, CA 90670
877-872-4844     866-872-4844

male pharmacist

Mr. Thomas J Roberson, RPH


Pharmacist
11721 Telegraph Rd, I, Santa Fe Springs, CA 90670
562-949-1003     562-949-3347

male pharmacist

Timothy Chock Hin Ng, PHARMD


Pharmacist
11980 Telegraph Rd Ste 100, Santa Fe Springs, CA 90670
562-347-2900    

female pharmacist

Tina Xuan Pham, PHARM.D.


Pharmacist
12540 Mccann Dr, Santa Fe Springs, CA 90670
714-664-0518    

male pharmacist

Tung Trinh


Pharmacist
11980 Telegraph Rd Ste 100, Santa Fe Springs, CA 90670
646-820-8864    

female pharmacist

Uyen Lam Truong, PHARMD


Pharmacist
12540 Mccann Dr, Santa Fe Springs, CA 90670
714-664-0518    

female pharmacist

Xiaoxiao Zhao


Pharmacist
12540 Mccann Dr, Santa Fe Springs, CA 90670
714-664-0518    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.